:: Dhanush Infotech ::

Home > Industries > Pharmaceutical

Pharmaceutical

Solutions designed to help you gain that Competitive Edge!

While maintaining strict adherence to quality principles, and regulatory requirements, Pharmaceutical companies are facing continual pressure to improve product pipelines, accelerate time to market, and improve margins on existing products.

To cater to industry requirements, we have partnered with Oracle, to provide Pharmaceutical companies with cost effective solution to speed up their product development cycle. Combined with world class PLM expertise and end-to-end implementation methodology our services can help increase revenue, and reduce the risk of non-compliance.

Dhanush Rapid Implementation Technique:

We initiate the implementation process by pre-populating Oracle Agile PLM and minimizing configuration effort. Pre-configuration includes specification template, workflows and profiles based on industry best practices, which help us to reduce the deployment time. We provide a rapid business process documentation which facilitates easy user adoption, streamlined data migration, and seamless integration with your ERP.

Dhanush Product Life Cycle Management Benefits:

PLM addresses the challenges of managing a portfolio of drug candidates, from disparate R & D facilities and manufacturing plants across the globe
Decreased time-to-market – Due to faster pack changes and new pack introduction process
Inherent focus on time-to-market and product development, which are key business priorities
Improved time to complete changes in the lifecycle of product
Better data management, compliance monitoring and collaboration
Reduced Product and Operational Costs:
- Lower material costs due to re-use and component standardization
- Lower scrap rates due to consistency of product specification and early vision into product component changes
- Greater packaging change through existing organizational resources
- Technology transfer of sites that give economies of scale or enable cost reduction
Greater compliance with regulatory requirements
Automate research processes and electronic trails that reduce non-compliance errors
Meets all requirements of Title 21 of the U.S. FDA Code of Federal Regulation (CFR) Part 11, which prescribes the accepted use of electronic records and signatures